COL11 antibodies are validated across diverse methodologies:
Genetic Disorders: Mutations in COL11A1 cause Stickler syndrome, Marshall syndrome, and fibrochondrogenesis, leading to skeletal and ocular abnormalities .
Cancer: Overexpression correlates with poor prognosis, chemoresistance, and immune infiltration in lung adenocarcinoma, breast cancer, and ovarian cancer .
ECM Remodeling: COL11A1 secreted by cancer-associated fibroblasts (CAFs) promotes tumor stiffness and metastasis .
Developmental Biology: Critical for zebrafish craniofacial cartilage formation, validated via knockout models .
Specificity: Confirmed via COL11A1 knockout zebrafish and peptide competition assays .
Cross-Reactivity: Human-specific in most cases; zebrafish-specific antibodies available .